adynovate rurioctocog alfa pegol (rch) 500 iu powder for injection vial with diluent vial
takeda pharmaceuticals australia pty ltd - water for injections, quantity: 5.4 ml - injection, solution - excipient ingredients: - adynovate is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia a (congenital factor viii deficiency) patients for:,? control and prevention of bleeding episodes,? routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? perioperative management (surgical prophylaxis),adynovate is not indicated for the treatment of von willebrand disease.
adynovate rurioctocog alfa pegol (rch) 250 iu powder for injection vial with diluent vial
takeda pharmaceuticals australia pty ltd - water for injections, quantity: 5.4 ml - injection, solution - excipient ingredients: - adynovate is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia a (congenital factor viii deficiency) patients for:,? control and prevention of bleeding episodes,? routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? perioperative management (surgical prophylaxis),adynovate is not indicated for the treatment of von willebrand disease.
recombinate 250 iu powder and solvent for solution for injection
baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - octocog alfa - powder and solvent for solution for injection - octocog alfa 25 iu/ml - antihemorrhagics
recombinate 500iu powder and solvent for solution for injection
baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - octocog alfa - powder and solvent for solution for injection - octocog alfa 500 iu - antihemorrhagics
recombinate 1000iu powder and solvent for solution for injection
baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - octocog alfa - powder and solvent for solution for injection - octocog alfa 1000 iu - antihemorrhagics
kogenate bayer
bayer ag - octocog alfa - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor-viii deficiency).this preparation does not contain von willebrand factor and is therefore not indicated in von willebrand's disease.
jivi
bayer ag - damoctocog alfa pegol - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in previously treated patients ≥ 12 years of age with haemophilia a (congenital factor viii deficiency).
iblias
bayer ag - octocog alfa - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).iblias can be used for all age groups.
obizur
baxalta innovations gmbh - susoctocog alfa - hemophilia a - antihemorrhagics - treatment of bleeding episodes in patients with acquired haemophilia caused by antibodies to factor viii. obizur is indicated in adults.
adynovi
baxalta innovations gmbh - rurioctocog alfa pegol - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients 12 years and above with haemophilia a (congenital factor viii deficiency).